CDC Panel Recommends RSV Vaccine for Pregnant Women

The advisory committee on immunizations for the CDC voted to recommend an RSV vaccine designed to give newborn infants protection against the virus before they’re born. The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 11-1 in favor of approving Pfizer’s Abrysvo for use in pregnant women during weeks 32 through 36 of gestation.

The vaccine is designed to induce antibodies in pregnant mothers who will then pass those on to their children, giving them protection in the first 6 months of life when they are particularly vulnerable to severe cases of disease. Learn more from The Hill here.